bluebird bio
BLUE
$6.72
Share price
6.50%
Change (1 day)
-63.62%
Change (1 year)
Market capitalization of bluebird bio (BLUE)
Market cap: $0.51 Billion
As of August 2022 bluebird bio has a market cap of $0.51 Billion. This makes bluebird bio the world's 5192th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of bluebird bio from 2013 to 2022
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2022 | $0.51 B | -26% |
| 2021 | $0.70 B | -75.61% |
| 2020 | $2.87 B | -40.89% |
| 2019 | $4.85 B | -10.52% |
| 2018 | $5.43 B | -37.87% |
| 2017 | $8.74 B | 279.73% |
| 2016 | $2.30 B | -2.86% |
| 2015 | $2.36 B | -20.12% |
| 2014 | $2.96 B | 490.57% |
| 2013 | $0.50 B |
End of Day market cap according to different sources
On Aug 14th, 2022 the market cap of bluebird bio was reported to be:
$0.47 Billion
$0.51 Billion
$0.48 Billion
$0.51 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $110.96 B | 21,310.95% | 🇫🇷 France |
 Merck MRK | $230.57 B | 44,391.15% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | $0.99 B | 91.21% | 🇺🇸 USA |
 Acceleron Pharma XLRN | $10.93 B | 2,009.29% | 🇺🇸 USA |
 GlycoMimetics
GLYC | $46.11 M | -91.10% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $17.63 B | 3,302.36% | 🇺🇸 USA |